Digital Health News | pharmaphorum

News

AstraZeneca links with Absci on AI for biologics discovery

AstraZeneca has agreed a deal worth up to $247 million with US generative artificial intelligence (GenAI) company Absci that will focus on the discovery of a new antibody-

News

MSD, Amgen back patient data specialist Culmination Bio

The venture capital arms of MSD and Amgen have provided $10 million in funding to Culmination Bio, a Utah start-up that aims to build the largest disease-agnostic patient

News

Start-up Cradle tucks in $24m for protein engineering AI

Dutch-Swiss start-up Cradle has raised €22 million ($24 million) in first-round financing to develop its generative artificial intelligence (GenAI) and synthetic biology p

News

Boehringer puts IBM's GenAI into its antibody discovery tank

In another example of the pharma industry embracing generative artificial intelligence (GenAI), Boehringer Ingelheim will use technology developed by IBM to rev up antibod

News

EVERSANA brings GenAI to medical content approvals

EVERSANA’s alliance with Amazon Web Services (AWS) on the application of generative artificial intelligence (GenAI) to the pharma sector has borne its first fruit – a new

News

Digital programme improves metabolic health in diabetes

A comprehensive digital approach to helping patients manage type 2 diabetes, combining continuous glucose monitoring (CGM) devices, wearables and a mobile app, has been sh

AstraZeneca links with Absci on AI for biologics discovery

MSD, Amgen back patient data specialist Culmination Bio

Start-up Cradle tucks in $24m for protein engineering AI

Boehringer puts IBM's GenAI into its antibody discovery tank

EVERSANA brings GenAI to medical content approvals

Digital programme improves metabolic health in diabetes

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

News

Editor's Picks